Bristol Myers Squibb (BMYMP) Change in Acquisitions & Divestments (2016 - 2025)
Bristol Myers Squibb (BMYMP) has disclosed Change in Acquisitions & Divestments for 17 consecutive years, with $1.9 billion as the latest value for Q4 2025.
- Quarterly Change in Acquisitions & Divestments rose 340.75% to $1.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Dec 2025, up 645.28% year-over-year, with the annual reading at $2.0 billion for FY2025, 645.28% up from the prior year.
- Change in Acquisitions & Divestments for Q4 2025 was $1.9 billion at Bristol Myers Squibb, up from $49.0 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $2.1 billion in Q3 2021, with the low at -$3.6 billion in Q3 2022.
- Average Change in Acquisitions & Divestments over 5 years is $361.5 million, with a median of $148.0 million recorded in 2023.
- The sharpest move saw Change in Acquisitions & Divestments soared 106800.0% in 2021, then crashed 267.21% in 2022.
- Over 5 years, Change in Acquisitions & Divestments stood at $1.2 billion in 2021, then crashed by 99.6% to $5.0 million in 2022, then soared by 2860.0% to $148.0 million in 2023, then tumbled by 637.16% to -$795.0 million in 2024, then skyrocketed by 340.75% to $1.9 billion in 2025.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $1.9 billion, $49.0 million, and -$208.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.